Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-102630 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 11, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
65,758
Total Value
$3,015,673.35
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Mar 11, 2026 | Exercise/Conversion | 20,000 | $43.50 | $870,000.00 | 93,810 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 11, 2026 | Sale | 1,765 | $82.13 | $144,955.04 | 92,045 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 11, 2026 | Sale | 12,882 | $83.10 | $1,070,510.95 | 79,163 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 11, 2026 | Sale | 11,111 | $83.72 | $930,207.36 | 68,052 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Mar 11, 2026 | Exercise/Conversion | 20,000 | $0.00 | $0.00 | 60,548 | Direct | โ | View Details |